Tower Research Capital LLC (TRC)
Position in NRIX — Nurix Therapeutics, Inc.
CIK 1533421
NEW YORK, NY
Position in NRIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$46,967
-$191,733 QoQ
Shares Held
1,936
-87.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#166
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,486,372 across 465 Biotechnology names. NRIX ranks #142 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,967 | 1,936 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $238,700 | 15,400 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $85,573 | 4,511 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $38,188 | 4,133 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $73,044 | 6,413 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $34,903 | 2,938 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $280,432 | 14,885 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $64,016 | 2,849 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $137,825 | 6,604 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $19,080 | 1,298 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $243,603 | 23,605 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,979 | 888 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $26,213 | 2,624 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $98,603 | 11,104 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $7,674 | 699 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $130,755 | 10,035 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $57,382 | 4,529 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $29,784 | 2,126 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $135,630 | 4,685 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $81,940 | 2,735 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $77,201 | 2,910 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $111,799 | 3,596 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $85,553 | 2,602 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $62,418 | 1,788 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||